Interactive Investor
>>

3SBio Inc (SEHK:1530) Share Price

1530

3SBio Inc

APAC company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

NAV Price

-

Last Traded

-

Chg

-

-

XHKG

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT+8, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2020, it reported revenue of CNY 5.6 billion. Approximately 75% of its revenue is derived from three core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), and EPIAO (rhEPO), which are all older generation biologics. The company has a pipeline of 32 products, of which 22 are biologics and 10 are small molecules, but most of the candidates are still at an early stage.3SBio Inc is a part of the Chinese healthcare sector. Its business comprises of developing and marketing pharmaceutical products in China. Its main products include TPIAO and Yisaipu.

SEHK:1530

KYG8875G1029

HKD

Loading...

Loading Comparison

Latest 1530 News